Symmetry Medical, Inc. (SMA) Cash Flow Statement

Click line-items for a historical chart and %

Net income	-3.98M
Depreciation	12.05M
Amortization
Net (gain) loss on sale of assets
Deferred income tax provision	-4.46M
Stock-based compensation	2.72M
Derivative valuation gain	0
Foreign currency transaction (gain) loss	-1.31M
Accounts receivable	-3.84M
Other assets	301K
Inventories	-442K
Current income taxes	3.55M
Accounts payable	1.79M
Accrued expenses and other	5.83M
Net cash provided by operating activities	33.83M
Purchases of property and equipment	-11.4M
Proceeds from the sale of property and equipment	1.6M
Net cash used in investing activities	-9.8M
Proceeds from revolving credit agreement borrowings	79.84M
Payments on revolving credit agreement borrowings	-64.84M
Proceeds from (payments on) short term borrowings, net	20.64M
Issuance of bank term loan
Payments on bank term loans and capital lease obligations	-17.35M
Proceeds from the issuance of common stock	-142K
Net cash used in financing activities	-2.43M
Effect of exchange rate changes on cash	-1.79M
Net increase (decrease) in cash and cash equivalents	19.81M
Cash and cash equivalents at beginning of period	7.36M
Cash and cash equivalents at end of period	27.18M
Cash paid for interest	5.2M
Cash paid for income taxes

Entities mentioned with SMA

View All Entities